Editorial – Moving forward on the pathway of targeted immunotherapies for type 1 diabetes: The importance of disease heterogeneity

M. Infante, C. Ricordi

Research output: Contribution to journalEditorial

Original languageEnglish (US)
Pages (from-to)8702-8704
Number of pages3
JournalEuropean review for medical and pharmacological sciences
Volume23
Issue number19
DOIs
StatePublished - Jan 1 2019

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this